Ivacaftor may reduce respiratory infections in cystic fibrosis - Healio

Ivacaftor may reduce respiratory infections in cystic fibrosis  Healio

Among patients with cystic fibrosis, the use of ivacaftor was associated with a 32% reduction in the rate of Pseudomonas aeruginosa infection and a 15% ...